Randomized Trial Comparing Cisplatin With Cisplatin Plus Intravenous Navelbine® in the Treatment of Previously Untreated, Stage IV Non-Small Cell Lung Cancer Patients
Publication Information Expand/Collapse
PMid: PMID29370458 | PMC number: PMC5963502
The association between ASCO Value framework and scientific and clinical impact of SWOG phase III clinical trials
Survival by Hispanic Ethnicity Among Cancer Patients participating in SWOG Clinical Trials
PMid: PMID28586789; PMC5710507
PMid: PMID24627276 | PMC number: PMC3982777
Association between BMI at treatment initiation and cancer survival across multiple SWOG trials
PMid: PMID23910067 | PMC number: PMC4122504
PMid: PMID23669424 | PMC number: PMC4131693
Racial disparities in survival of patients with sex-specific cancers treated on Southwest Oncology Group clinical trials. PMC2724852; PMID: 19584328
Chemotherapy outcomes by histologic subtype of non-small cell lung cancer (NSCLC): analysis of the SWOG database for antimicrotubule-platinum therapy
Minority report: how best to analyze clinical trial data to address disparities
The Southwest Oncology Group: progress in cancer research [PMID18929152]
Toxicity and survival by sex in patients with advanced non small cell lung carcinoma (NSCLC) on modern Southwest Oncology Group (SWOG) trials.
Should older patients (PTS) receive combination chemotherapy for advanced stage non-small cell lung cancer (NSCLC)? an analysis of Southwest Oncology trials 9509 and 9308.
Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: A Southwest Oncology Group study.
Randomized phase III trial of cisplatin (CDDP) vs CDDP plus navelbine (NVB) in treatment of advanced non-small cell lung cancer (NSCLC): An update of a Southwest Oncology Group study (SWOG 9308).
Randomized phase III trial of cisplatin (CDDP) vs. CDDP plus navelbine (NVB) in treatment of advanced non-small cell lung cancer (NSCLC): Report of a Southwest Oncology Group study (SWOG-9308).